International Online Medical Council (IOMC)

Citations Report

Journal of Neurology & Neurophysiology : Citations & Metrics Report

Articles published in Journal of Neurology & Neurophysiology have been cited by esteemed scholars and scientists all around the world. Journal of Neurology & Neurophysiology has got h-index 17, which means every article in Journal of Neurology & Neurophysiology has got 17 average citations.

Following are the list of articles that have cited the articles published in Journal of Neurology & Neurophysiology.

	2022	2021	2020	2019	2018
Year wise published articles	60	60	24	25	26
Year wise citations received	200	239	223	219	187

Journal total citations count	1487
Journal Impact Factor	3.20
Journal 5 years Impact Factor	4.17
Journal CiteScore	4.13
Journal h-index	17

Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
CiteScore_y = Citations_y + Citations_y-1 + Citations_y-2 + Citations _y-3 / Published articles_y + Published articles_y-1 + Published articles_y-2 + Published articles _y-3

Important Citations

Zhang, W., Houb, S. T., & Stanimirovic, D. Blood Brain Barrier Protection in Stroke: Taming tPA. View at Publisher View at Google Scholar
Caga, J., Hsieh, S., Lillo, P., Dudley, K., & Mioshi, E. (2019). The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Frontiers in neurology, 10, 192. View at Publisher View at Google Scholar
Park, S. H., Jang, S., Lee, S. W., Park, S. D., Sung, Y. Y., & Kim, H. K. (2018). Akebia quinata Decaisne aqueous extract acts as a novel anti-fatigue agent in mice exposed to chronic restraint stress. Journal of ethnopharmacology, 222, 270-279. View at Publisher View at Google Scholar
Eyileten, C., Sharif, L., Wicik, Z., Jakubik, D., Jarosz-Popek, J., Soplinska, A., ... & Mirowska-Guzel, D. (2021). The relation of the brain-derived neurotrophic factor with microRNAs in neurodegenerative diseases and ischemic stroke. Molecular neurobiology, 58(1), 329-347. View at Publisher View at Google Scholar
Oskarsson, B., Gendron, T. F., & Staff, N. P. (2018, November). Amyotrophic lateral sclerosis: an update for 2018. In Mayo Clinic Proceedings (Vol. 93, No. 11, pp. 1617-1628). Elsevier. View at Publisher View at Google Scholar
Boissoneault, J., Letzen, J., Robinson, M., & Staud, R. (2019). Cerebral blood flow and heart rate variability predict fatigue severity in patients with chronic fatigue syndrome. Brain imaging and behavior, 13(3), 789-797. View at Publisher View at Google Scholar
Landi, A., Broadhurst, D., Vernon, S. D., Tyrrell, D. L. J., & Houghton, M. (2016). Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome. Cytokine, 78, 27-36. View at Publisher View at Google Scholar
Kolotsios, K. (2015). Literature review in field of drugs influencing blood clotting. View at Publisher View at Google Scholar
Tripathy, K. (2011). Epigenetic and therapeutic analysis of various neurological disorders. J. Genet. Syndr. Gene Ther, 2. View at Publisher View at Google Scholar
Sari, I. M., & Islam, M. S. (2016). The Comparison between Deficit Functional Neurologist with Von Willebrand Factor Levels in Acute Thrombotic Stroke Patients. Malang Neurology Journal, 2(1), 1-8. View at Publisher View at Google Scholar
Poologaindran, A. (2017). The neurosurgical treatment of spasmodic dysphonia: thinking outside the voice box (Doctoral dissertation, University of British Columbia). View at Publisher View at Google Scholar
Swendeman, S. L., Xiong, Y., Cantalupo, A., Yuan, H., Burg, N., Hisano, Y., ... & Hla, T. (2017). An engineered S1P chaperone attenuates hypertension and ischemic injury. Science signaling, 10(492). View at Publisher View at Google Scholar
Honey, C. M., Hart, M. G., Rammage, L. A., Morrison, M. D., Hu, A., & Honey, C. R. (2021). Thalamic Deep Brain Stimulation Ameliorates Mixed and Abductor Spasmodic Dysphonia: Case Reports and Proof of Concept. Neurosurgery Open, 2(3), okab022. View at Publisher View at Google Scholar
Tersteeg, C., De Meyer, S. F., & Deckmyn, H. (2017). Inhibitors of platelet adhesion to VWF and collagen. In Platelets in Thrombotic and Non-Thrombotic Disorders (pp. 1313-1323). Springer, Cham. View at Publisher View at Google Scholar
Enver, N., & Pitman, M. J. (2020). What Is New in Laryngeal Dystonia: Review of Novel Findings of Pathophysiology and Novel Treatment Options. Current Otorhinolaryngology Reports, 1-7. View at Publisher View at Google Scholar
Lapchak, P. A., & Boitano, P. D. (2017). Reflections on neuroprotection research and the path toward clinical success. In Neuroprotective Therapy for Stroke and Ischemic Disease (pp. 3-71). Springer, Cham. View at Publisher View at Google Scholar
Denorme, F., Vanhoorelbeke, K., & De Meyer, S. F. (2019). von Willebrand factor and platelet glycoprotein Ib: a thromboinflammatory axis in stroke. Frontiers in immunology, 10, 2884. View at Publisher View at Google Scholar
Mahnan, A. (2021). Vibro tactile stimulation as a treatment for the voice disorder spasmodic dysphonia (Doctoral dissertation, University of Minnesota). View at Publisher View at Google Scholar
Reimann, A., Li, Z., Goebel, S., Fassbender, J., Holthoff, H. P., Gawaz, M., ... & Ungerer, M. (2016). Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke. Heart international, 11(1), heartint-5000229. View at Publisher View at Google Scholar
Olthoff, A., Grosheva, M., Reichel, G., Volk, G. F., & Laskawi, R. (2017). Die Behandlung der laryngealen Dystonie mit Botulinumtoxin. Fortschritte der Neurologie· Psychiatrie, 85(08), 450-462. View at Publisher View at Google Scholar
Prev 1 2 ... 27 28 29 30 31 32 33 34 35 36 37 ... 84 85 Next »

Journal of Neurology & Neurophysiology

Citations Report

Journal of Neurology & Neurophysiology : Citations & Metrics Report

Important Citations

Zhang, W., Houb, S. T., & Stanimirovic, D. Blood Brain Barrier Protection in Stroke: Taming tPA.

Caga, J., Hsieh, S., Lillo, P., Dudley, K., & Mioshi, E. (2019). The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Frontiers in neurology, 10, 192.

Park, S. H., Jang, S., Lee, S. W., Park, S. D., Sung, Y. Y., & Kim, H. K. (2018). Akebia quinata Decaisne aqueous extract acts as a novel anti-fatigue agent in mice exposed to chronic restraint stress. Journal of ethnopharmacology, 222, 270-279.

Eyileten, C., Sharif, L., Wicik, Z., Jakubik, D., Jarosz-Popek, J., Soplinska, A., ... & Mirowska-Guzel, D. (2021). The relation of the brain-derived neurotrophic factor with microRNAs in neurodegenerative diseases and ischemic stroke. Molecular neurobiology, 58(1), 329-347.

Oskarsson, B., Gendron, T. F., & Staff, N. P. (2018, November). Amyotrophic lateral sclerosis: an update for 2018. In Mayo Clinic Proceedings (Vol. 93, No. 11, pp. 1617-1628). Elsevier.

Boissoneault, J., Letzen, J., Robinson, M., & Staud, R. (2019). Cerebral blood flow and heart rate variability predict fatigue severity in patients with chronic fatigue syndrome. Brain imaging and behavior, 13(3), 789-797.

Landi, A., Broadhurst, D., Vernon, S. D., Tyrrell, D. L. J., & Houghton, M. (2016). Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome. Cytokine, 78, 27-36.

Kolotsios, K. (2015). Literature review in field of drugs influencing blood clotting.

Tripathy, K. (2011). Epigenetic and therapeutic analysis of various neurological disorders. J. Genet. Syndr. Gene Ther, 2.

Sari, I. M., & Islam, M. S. (2016). The Comparison between Deficit Functional Neurologist with Von Willebrand Factor Levels in Acute Thrombotic Stroke Patients. Malang Neurology Journal, 2(1), 1-8.

Poologaindran, A. (2017). The neurosurgical treatment of spasmodic dysphonia: thinking outside the voice box (Doctoral dissertation, University of British Columbia).

Swendeman, S. L., Xiong, Y., Cantalupo, A., Yuan, H., Burg, N., Hisano, Y., ... & Hla, T. (2017). An engineered S1P chaperone attenuates hypertension and ischemic injury. Science signaling, 10(492).

Honey, C. M., Hart, M. G., Rammage, L. A., Morrison, M. D., Hu, A., & Honey, C. R. (2021). Thalamic Deep Brain Stimulation Ameliorates Mixed and Abductor Spasmodic Dysphonia: Case Reports and Proof of Concept. Neurosurgery Open, 2(3), okab022.

Tersteeg, C., De Meyer, S. F., & Deckmyn, H. (2017). Inhibitors of platelet adhesion to VWF and collagen. In Platelets in Thrombotic and Non-Thrombotic Disorders (pp. 1313-1323). Springer, Cham.

Enver, N., & Pitman, M. J. (2020). What Is New in Laryngeal Dystonia: Review of Novel Findings of Pathophysiology and Novel Treatment Options. Current Otorhinolaryngology Reports, 1-7.

Lapchak, P. A., & Boitano, P. D. (2017). Reflections on neuroprotection research and the path toward clinical success. In Neuroprotective Therapy for Stroke and Ischemic Disease (pp. 3-71). Springer, Cham.

Denorme, F., Vanhoorelbeke, K., & De Meyer, S. F. (2019). von Willebrand factor and platelet glycoprotein Ib: a thromboinflammatory axis in stroke. Frontiers in immunology, 10, 2884.

Mahnan, A. (2021). Vibro tactile stimulation as a treatment for the voice disorder spasmodic dysphonia (Doctoral dissertation, University of Minnesota).

Reimann, A., Li, Z., Goebel, S., Fassbender, J., Holthoff, H. P., Gawaz, M., ... & Ungerer, M. (2016). Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke. Heart international, 11(1), heartint-5000229.

Olthoff, A., Grosheva, M., Reichel, G., Volk, G. F., & Laskawi, R. (2017). Die Behandlung der laryngealen Dystonie mit Botulinumtoxin. Fortschritte der Neurologie· Psychiatrie, 85(08), 450-462.

Journal Highlights

Journal Flyer

+1-845-458-6882